EUVIMEDScopri EUVIMED
EUVIMED · CrossrefJournal

Breast Cancer

ISSN 1340-6868 · Springer Science and Business Media LLC

Latest articles

  1. Longitudinal PRO-CTCAE assessment in patients with HR+/HER2 − metastatic breast cancer initiating palbociclib: feasibility and symptom trajectories in a multicenter prospective cohort study

    Takayuki Iwamoto, Yukari Uemura, Takashi Ishikawa, Azusa Jo, Hirohito Seki, Masahiro Kitada, Tsuyoshi Saito, Kimito Yamada, Shintaro Takao, Daisuke Takabatake, Toru Yokota, Yasuo Hozumi, Yuichiro Kikawa, Akimitsu Yamada, Uhi Toh, Hideki Nishimura, Hiroshi Kaise, Kazuhiko Yamagami, Reiki Nishimura, Kazutaka Narui, Hirofumi Mukai, Naruto Taira

    Published: 2026-11-06DOI: 10.1007/s12282-026-01936-2

  2. Differences in drug efficacy and prognosis between primary and metastatic sites for de novo stage IV breast cancer: an exploratory analysis of a phase III trial, JCOG1017

    Kiyo Tanaka, Akihiko Shimomura, Makoto Ishitobi, Takashi Yamanaka, Takahiro Tsukioki, Hiroji Iwata, Fumikata Hara, Tomomi Fujisawa, Keita Sasaki, Ryo Sadachi, Riku Kajikawa, Takehiko Sakai, Yasuaki Sagara, Hideo Shigematsu, Yukinori Ozaki, Kazuki Nozawa, Kazuki Sudo, Yoichi Naito, Kaori Terata, Toshiyuki Ishiba, Haruhiko Fukuda, Tadahiko Shien

    Published: 2026-07DOI: 10.1007/s12282-026-01846-3

  3. Comparative evaluation of treatment recommendations generated by generative AI and breast cancer specialists for advanced and recurrent breast cancer: a multidimensional assessment of evidence interpretation and clinical decision support

    Maiko Nishida, Rie Tou, Hiroki Kato, Nagisa Hirotani, Sae Kitano, Yuka Okuyama, Chise Matsui, Saya Matsumoto, Akira Watanabe, Erika Iguchi, Mahiro Iizuka-Ohashi, Chikage Kato, Midori Morita, Koichi Sakaguchi, Kengo Yoshii, Yasuto Naoi

    Published: 2026-07DOI: 10.1007/s12282-026-01858-z

  4. Correction: Differences in drug efficacy and prognosis between primary and metastatic sites for de novo stage IV breast cancer: an exploratory analysis of a phase III trial, JCOG1017

    Kiyo Tanaka, Akihiko Shimomura, Makoto Ishitobi, Takashi Yamanaka, Takahiro Tsukioki, Hiroji Iwata, Fumikata Hara, Tomomi Fujisawa, Keita Sasaki, Ryo Sadachi, Riku Kajikawa, Takehiko Sakai, Yasuaki Sagara, Hideo Shigematsu, Yukinori Ozaki, Kazuki Nozawa, Kazuki Sudo, Yoichi Naito, Kaori Terata, Toshiyuki Ishiba, Haruhiko Fukuda, Tadahiko Shien

    Published: 2026-07DOI: 10.1007/s12282-026-01874-z

Volumes

2026 · 1602025 · 1492024 · 1242023 · 1092022 · 1152021 · 1472020 · 1402019 · 1042018 · 1002017 · 1082016 · 1242015 · 922014 · 1122013 · 592012 · 602011 · 552010 · 582009 · 572008 · 582007 · 742006 · 692005 · 682004 · 692003 · 632002 · 642001 · 592000 · 721999 · 691998 · 661997 · 551996 · 351995 · 211994 · 24

Conoscenze adatte al tuo lavoro.

Dall’inizio gratuito alla ricerca bibliografica personale, fino alla Research Suite completa.

Visualizza tariffe →

Sono inclusi tutti i testi integrali degli editori?

No. Citazioni, abstract e testi integrali sono contenuti diversi. La disponibilità dipende dalla fonte, dall’accesso aperto e dalle licenze esistenti. Un piano EUVIMED non sostituisce diritti aggiuntivi degli editori.